EMEA-001526-PIP01-13-M04
Table of contents
Key facts
Invented name |
Natpar
|
Active substance |
Recombinant parathyroid hormone
|
Therapeutic area |
Endocrinology, -gynacology-fertility-metabolism
|
Decision number |
P/0460/2020
|
PIP number |
EMEA-001526-PIP01-13-M04
|
Pharmaceutical form(s) |
Powder and solvent for solution for injection
|
Condition(s) / indication(s) |
Treatment of hypoparathyroidism
|
Route(s) of administration |
Subcutaneous use
|
Contact for public enquiries |
Shire Pharmaceuticals Ireland Limited
Tel. +800 6683 8470 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|